NCT07175363

Butorphanol for Pain Relief After Cesarean Section: A Retrospective Study

The Application of Butorphanol in Postoperative Analgesia Management After Cesarean Section: A Retrospective Cohort Study

• Status: Not Yet Recruiting
• Phase: —
• Study type: Observational
• Enrollment: 2,500 (estimated)
• Sponsor: Sichuan Provincial People's Hospital · Academic / Other
• Sex: Female
• Age: 18 Years – 55 Years
• Healthy volunteers: Not accepted

Summary

This study explored the association between postoperative functional recovery and the formula of analgesic pumps as well as other related factors (such as age, intraoperative blood loss, operation duration, etc.) by retrospectively analyzing the clinical data of patients undergoing cesarean section in the main campus and branches of Sichuan Provincial People's Hospital from September 2024 to June 2025. The value of this study lies in: 1) providing a basis for optimizing the postoperative analgesia plan after cesarean section. 2) To provide references for the formulation of personalized analgesia strategies in clinical practice, improve the postoperative recovery quality of patients, promote the concept of enhanced recovery after surgery, and reduce the medical burden.

Conditions

• Caesarean Section

Interventions

Type	Name	Description
DRUG	An postoperative analgesic pump was used	The drugs in the analgesic pump include butorphanol, hydromorphone, tramadol, and other medications.

Timeline

• Start date: 2025-09-20
• Primary completion: 2025-09-30
• Completion: 2026-06-30
• First posted: 2025-09-16
• Last updated: 2025-09-16